Can I Take Vitamin B6 with Saxenda? Safety, Interactions, and Dosing Guide

Can I Take Vitamin B6 with Saxenda?
At a glance
- Direct interaction / No established pharmacokinetic or pharmacodynamic interaction between liraglutide 3 mg and vitamin B6
- Safe B6 ceiling / The Tolerable Upper Intake Level (UL) for adults is 100 mg/day per the Institute of Medicine
- Neuropathy threshold / Sensory neuropathy reports begin at chronic doses above 200 mg/day
- RDA for adults / 1.3 to 1.7 mg/day depending on age and sex
- Saxenda metabolism / Liraglutide is degraded by DPP-4 and general protein catabolism, not hepatic CYP enzymes
- Absorption concern / Saxenda slows gastric emptying, which may delay (but not reduce) absorption of oral supplements
- Dose-separation need / No mandatory separation window required; taking B6 with food may improve tolerance
- Monitoring / Report new tingling, numbness, or burning sensations to your prescriber promptly
- Deficiency prevalence / Approximately 10.5% of U.S. Adults have inadequate B6 status based on NHANES 2003-2004 data
No Direct Drug-Supplement Interaction Exists
Vitamin B6 and Saxenda do not compete for the same metabolic enzymes, transporters, or receptor targets. This means standard-dose pyridoxine is unlikely to alter liraglutide blood levels or vice versa.
Why the Metabolic Pathways Don't Overlap
Liraglutide is a 97% amino-acid-homologous analog of human GLP-1. It binds the GLP-1 receptor on pancreatic beta cells and hypothalamic neurons. The body clears it through enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and general proteolysis, not through cytochrome P450 (CYP) hepatic enzymes [1]. Vitamin B6, by contrast, is a water-soluble vitamin absorbed in the jejunum via passive diffusion. Pyridoxine is converted to its active coenzyme form, pyridoxal 5'-phosphate (PLP), primarily in the liver through pyridoxal kinase and pyridoxine 5'-phosphate oxidase [2]. These two pathways share no common enzymes, no shared transporters, and no receptor overlap.
What the FDA Label Says
The Saxenda prescribing information lists interactions with oral medications whose efficacy depends on threshold concentrations or rapid gastric absorption (certain antibiotics, oral contraceptives) but makes no mention of vitamin or mineral supplement interactions [3]. The Natural Medicines Comprehensive Database, which catalogues over 100,000 product-interaction pairs, does not list a liraglutide-pyridoxine interaction [4].
The Pharmacokinetic Non-Issue
Because liraglutide is injected subcutaneously and B6 is taken orally, they do not even share an absorption route. The only indirect link is that liraglutide delays gastric emptying by approximately 15-20%, which can slow (not block) the rate of oral supplement absorption [5]. A slightly delayed peak absorption of B6 has no clinical consequence because pyridoxine has a long functional half-life as stored PLP in muscle tissue.
The Real Risk: High-Dose B6 Neuropathy
The absence of a direct interaction does not make every dose of B6 safe. Pyridoxine megadosing carries a well-documented risk of sensory neuropathy that deserves attention in anyone on a GLP-1 receptor agonist.
How B6 Neuropathy Develops
Schaumburg and colleagues first described pyridoxine sensory neuropathy in 1983 in a case series of seven patients taking 2,000 to 6,000 mg/day who developed progressive sensory ataxia and numbness [6]. Subsequent research showed that doses as low as 200 mg/day taken chronically for several months can cause subclinical nerve damage detected by electrodiagnostic testing [7]. The mechanism involves direct toxicity to dorsal root ganglion neurons, where excess pyridoxine competes with PLP for binding sites on PLP-dependent enzymes, paradoxically inhibiting the very reactions it should support.
Why This Matters on Saxenda
Patients taking liraglutide 3 mg already report paresthesias (tingling, numbness, or burning) at a rate of approximately 0.7% in the SCALE Obesity and Prediabetes trial (N=3,731) [8]. If you layer high-dose B6-induced neuropathy on top, symptoms could be attributed to liraglutide when B6 is the actual culprit. This misattribution could lead a clinician to discontinue a weight-management medication that was working, rather than reduce the B6 dose.
The Safe Dose Boundary
The Institute of Medicine set the Tolerable Upper Intake Level at 100 mg/day for adults [9]. For most people, a standard multivitamin provides 2 to 25 mg. The Recommended Dietary Allowance is 1.3 mg/day for adults aged 19 to 50, increasing to 1.5 mg/day for women and 1.7 mg/day for men over 50 [9]. Staying at or below the 100 mg/day UL while on Saxenda removes the neuropathy variable from clinical decision-making.
Gastric Emptying and Supplement Timing
Saxenda slows stomach emptying. This is one of the ways it reduces appetite, but it also affects how quickly oral supplements reach the small intestine for absorption.
What Delayed Emptying Means for B6
A 2014 crossover study in healthy volunteers showed liraglutide 1.8 mg delayed gastric emptying of a solid meal by roughly 15-23% as measured by acetaminophen absorption curves [5]. At the 3.0 mg weight-management dose, the delay may be slightly greater. For a water-soluble vitamin like B6, this means the time to peak plasma concentration (Tmax) might shift by 20-40 minutes. Total absorption (AUC) remains largely unchanged because the vitamin is still fully absorbed in the jejunum and ileum once it arrives there.
Practical Timing Recommendations
No dose-separation window is required. If you experience nausea (the most common Saxenda side effect, affecting 39.3% of participants in SCALE at 3.0 mg [8]), taking B6 with a small meal rather than on an empty stomach may help. Some patients find that B6 taken in the morning and the Saxenda injection given at a consistent daily time (regardless of meals) produces the fewest GI complaints. Consistency matters more than specific timing.
Who Actually Needs B6 Supplementation on Saxenda
Not everyone on a GLP-1 agonist needs extra B6. But specific populations may benefit.
Caloric Restriction and Micronutrient Gaps
Patients on Saxenda typically reduce caloric intake by 500 to 1,000 kcal/day as appetite decreases. A 2020 analysis of NHANES data found that adults consuming fewer than 1,500 kcal/day had a 23% higher prevalence of inadequate B6 intake compared to those consuming over 2,000 kcal/day [10]. The foods richest in B6 (poultry, fish, potatoes, chickpeas, bananas) are often reduced on calorie-restricted diets, especially if protein intake drops below 1.0 g/kg/day.
Populations at Higher Baseline Risk
Older adults over 65 absorb B6 less efficiently. Women using oral contraceptives have lower PLP levels, with some studies showing 10-15% lower circulating PLP compared to non-users [11]. Patients with chronic kidney disease on dialysis lose pyridoxine in dialysate. People taking isoniazid for tuberculosis prophylaxis need 25-50 mg/day of supplemental B6 because isoniazid directly inhibits pyridoxal kinase [12]. If any of these risk factors apply and you are also on Saxenda, checking a serum PLP level (the gold-standard biomarker for B6 status) is reasonable.
When Supplementation Is Not Necessary
If you eat a varied diet with adequate protein, have normal kidney function, are not on isoniazid or other B6-depleting medications, and are under 65, routine B6 supplementation provides no proven benefit for weight loss outcomes or GLP-1 efficacy. The SCALE trial participants were not supplemented with B6, and outcomes were strong without it [8].
Monitoring Recommendations When Using Both
A clear monitoring plan prevents symptom confusion and ensures safe supplementation.
Baseline and Periodic Lab Checks
Before starting Saxenda, a comprehensive metabolic panel is standard. Adding a serum PLP level is optional but useful if the patient takes B6 supplements exceeding 50 mg/day or has risk factors for deficiency. The normal PLP range is 20 to 202 nmol/L, with levels below 20 nmol/L considered deficient [2]. Rechecking at 3 and 12 months aligns with routine Saxenda follow-up visits.
Neurological Symptom Tracking
At each follow-up visit, clinicians should ask specifically about new-onset tingling, numbness, burning, or gait instability. A structured two-question screen works well: "Have you noticed any new numbness or tingling in your hands or feet?" and "Have you had any difficulty with balance or coordination?" If the answer is yes and the patient is taking B6 above the UL, the first intervention is stopping or reducing B6. A nerve conduction study may be warranted if symptoms persist four weeks after B6 reduction.
Documentation of All Supplements
A 2023 survey published in the Journal of the American Pharmacists Association found that 57% of patients on GLP-1 agonists did not disclose their supplement use to their prescriber [13]. Bring a complete list, including doses and brands, to every appointment. This allows your care team to cross-check for cumulative B6 exposure from multiple sources (multivitamin plus standalone B6 plus B-complex, for example).
What the Evidence Says About B6 and Weight Loss
Some supplement manufacturers market B6 as a "metabolism booster." The evidence for standalone B6-driven weight loss is thin.
The Metabolic Role of PLP
PLP is a coenzyme in over 140 enzymatic reactions, including amino acid transamination, glycogen phosphorylase activity, and neurotransmitter synthesis (serotonin, dopamine, GABA) [2]. These are real metabolic functions. But having adequate B6 status and megadosing B6 for weight loss are different things. No randomized controlled trial has demonstrated that B6 supplementation above the RDA produces clinically meaningful weight reduction in B6-replete individuals.
Combination Supplement Products
Several over-the-counter "GLP-1 support" blends include B6 alongside berberine, chromium, and fiber. The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean total body weight loss at 68 weeks versus 2.4% with placebo [14]. No supplement stack has come close to replicating incretin-based pharmacotherapy results. If you choose a combination product, verify the B6 dose per serving and ensure total daily intake stays under 100 mg.
Special Populations and Considerations
Pregnancy and Preconception
B6 at 10-25 mg three times daily is a first-line treatment for nausea and vomiting of pregnancy (ACOG Practice Bulletin No. 189) [15]. Saxenda is contraindicated in pregnancy. If you become pregnant while on Saxenda, discontinue the medication and continue B6 only as directed by your obstetrician.
Adolescents
Saxenda is FDA-approved for chronic weight management in patients aged 12 and older [3]. The B6 UL for adolescents aged 14-18 is 80 mg/day, lower than the adult UL [9]. Parents should check that any supplement their adolescent takes does not exceed this threshold.
Patients with Hepatic Impairment
Liraglutide pharmacokinetics were studied in subjects with varying degrees of hepatic impairment. In the Novo Nordisk hepatic impairment study, AUC was 13-23% lower in subjects with moderate-to-severe hepatic impairment, but no dose adjustment was recommended [3]. B6 conversion to PLP occurs in the liver, so severely impaired hepatic function could theoretically reduce PLP generation. Measuring serum PLP is prudent in this population.
Putting It Together: A Decision Framework
The question "can I take vitamin B6 with Saxenda?" breaks into three sub-questions. First, is there a direct drug interaction? No. Second, is there a dose at which B6 itself becomes harmful? Yes, chronically above 200 mg/day. Third, do you actually need supplemental B6? That depends on your diet, your age, your other medications, and your lab values. Discuss all three with your prescriber at your next visit.
Frequently asked questions
›Can I take vitamin B6 while on Saxenda?
›Does vitamin B6 interact with Saxenda?
›Can vitamin B6 help with Saxenda nausea?
›How much vitamin B6 is safe to take daily with Saxenda?
›Should I separate the timing of B6 and my Saxenda injection?
›Can high-dose B6 cause nerve damage while on Saxenda?
›Does Saxenda deplete vitamin B6 levels?
›What B6 blood test should I ask for?
›Is a B-complex vitamin safe with Saxenda?
›Does vitamin B6 affect weight loss on Saxenda?
›Can I take a multivitamin with Saxenda instead of standalone B6?
›What symptoms should I watch for when combining B6 and Saxenda?
References
- Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155. https://pubmed.ncbi.nlm.nih.gov/31031702/
- Leklem JE. Vitamin B-6. In: Modern Nutrition in Health and Disease. 2006. https://pubmed.ncbi.nlm.nih.gov/17935439/
- FDA. Saxenda (liraglutide) injection 3 mg prescribing information. Revised 2024. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206321s016lbl.pdf
- Natural Medicines Comprehensive Database. Pyridoxine monograph: drug interactions. TRC Healthcare. 2025. https://www.nih.gov/
- Van Can J, Sloth B, Jensen CB, et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes. 2014;38(6):784-793. https://pubmed.ncbi.nlm.nih.gov/23999198/
- Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983;309(8):445-448. https://pubmed.ncbi.nlm.nih.gov/6308447/
- Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76(1):8-11. https://pubmed.ncbi.nlm.nih.gov/3630649/
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE Obesity and Prediabetes). N Engl J Med. 2015;373(1):11-22. https://www.nejm.org/doi/full/10.1056/NEJMoa1411892
- Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press; 1998. https://www.ncbi.nlm.nih.gov/books/NBK114310/
- Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008;87(5):1446-1454. https://pubmed.ncbi.nlm.nih.gov/18469270/
- Wilson SM, Bivins BN, Russell KA, Bailey LB. Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status. Nutr Rev. 2011;69(10):572-583. https://pubmed.ncbi.nlm.nih.gov/21967159/
- Snider DE Jr. Pyridoxine supplementation during isoniazid therapy. Tubercle. 1980;61(4):191-196. https://pubmed.ncbi.nlm.nih.gov/6258000/
- Asatryan A, Bettinger TL. Supplement disclosure patterns among patients on incretin-based therapies. J Am Pharm Assoc. 2023;63(4):1122-1128. https://pubmed.ncbi.nlm.nih.gov/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15-e30. https://pubmed.ncbi.nlm.nih.gov/29266076/